Objective: Patients with schizophrenia have a high prevalence of metabolic disorders and cardiovascular mortality. It is possible that a vulnerability to metabolic abnormalities is associated with risk for psychosis, symptoms and functionality. In this study, we evaluate demographic information, cardiometabolic indices, symptoms and functioning in an antipsychotic free cohort at Clinical High Risk (CHR) for psychosis from the NAPLS Omega 3 fatty acid clinical trial.
Method: Subjects received physical exams and metabolic monitoring prior to randomization into the Omega 3 versus Placebo trial. Anthropometrical measures, vital signs, glucose, and lipids were assessed along with symptoms, functioning, dietary Omega 3 fatty acids, erythrocyte polyunsaturated fatty acid content and a measure of lipid peroxidation (TBARS, Thiobarbituric acid-reactive substances).
Results: The sample included 113 CHR subjects (42.1% female; 17.5% Latino) ages 12-29. The mean BMI was 24.3 with a trend toward higher BMI and a higher incidence of metabolic syndrome in Latino subjects; 36% of the sample was obese/overweight; 37.6% met criteria for prehypertension/hypertension; 4.2% met criteria for prediabetes/diabetes; 9.6% showed evidence of insulin resistance and 44.7% had dyslipidemia. The TBARS was elevated at 9.8 μM ± 6.1 (normal 1.86-3.94 μM). Metabolic parameters and a diet low in Omega 3 rich foods were significantly associated with prodromal symptoms and poor functioning.
Conclusions: CHR subjects show a high percentage of metabolic abnormalities prior to exposure to antipsychotic medication. These findings reinforce that early detection of metabolic disturbances and food insecurity is crucial since these factors are modifiable with the potential for significant gains in terms of quality of life, physical and mental health.
Keywords: Clinical high risk; Fatty acid; Metabolic; Omega 3; Oxidative stress.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
Negative Symptoms and Impaired Social Functioning Predict Later Psychosis in Latino Youth at Clinical High Risk in the North American Prodromal Longitudinal Studies ConsortiumT Alderman et al. Early Interv Psychiatry 9 (6), 467-75. PMID 24576057.Based on this sample, Latino CHR subjects may seek treatment earlier and have less education than non-Latino CHR subjects. Deficits in social functioning and impaired per …
[Drawing Up Guidelines for the Attendance of Physical Health of Patients With Severe Mental Illness]D Saravane et al. Encephale 35 (4), 330-9. PMID 19748369.Patients on antipsychotic drugs should undergo regular testing of blood sugar, lipid profile, as well as body weight, waist circumference and blood pressure, with recomme …
Neuropsychology of the Prodrome to Psychosis in the NAPLS Consortium: Relationship to Family History and Conversion to PsychosisLJ Seidman et al. Arch Gen Psychiatry 67 (6), 578-88. PMID 20530007.These findings document that CHR individuals have significant neuropsychological difficulties, particularly those who later develop psychosis. This dysfunction is general …
[Lipids, Depression and Suicide]A Colin et al. Encephale 29 (1), 49-58. PMID 12640327. - ReviewSome epidemiological, experimental and clinical data favour the hypothesis that polyunsaturated fatty acids could play a role in the pathogenesis and/or the treatment of …
[Detection and Early Treatment of Subjects at High Risk of Clinical Psychosis: Definitions and Recommendations]C Michel et al. Encephale 43 (3), 292-297. PMID 28347521. - ReviewIn children and adolescents, psychotic disorders already represent one of the leading causes of disability-adjusted life years. During the past two decades, early detecti …
Cited by 3 PubMed Central articles
Polyunsaturated Fatty Acids: What Is Their Role in Treatment of Psychiatric Disorders?P Bozzatello et al. Int J Mol Sci 20 (21). PMID 31652770. - ReviewIn the central nervous system omega-3 fatty acids modulate cell signaling and affect dopaminergic and serotonergic pathways. On this basis, a new application for omega-3 …
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialM Berger et al. Front Psychiatry 10, 393. PMID 31244693.Background: Deficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty acids are thought to contribute to the pathophysiological proce …
Is Obesity in Young People With Psychosis a Foregone Conclusion? Markedly Excessive Energy Intake Is Evident Soon After Antipsychotic InitiationSB Teasdale et al. Front Psychiatry 9, 725. PMID 30618891.Introduction: Antipsychotic medication (APM) initiation is associated with rapid and substantial weight-gain and high rates of obesity. Obesity leads to premature …
- Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E, 2001. Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. J Psychopharmacol 15(4), 237–242. - PubMed
- Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP, 2003. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 53(1), 56–64. - PubMed
- Brown S, 1997. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 171, 502–508. - PubMed
- Buchholz S, Morrow AF, Coleman PL, 2008. Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms. Intern Med J 38(7), 602–606. - PubMed
- U01 MH082022/MH/NIMH NIH HHS/United States
- U01 MH081984/MH/NIMH NIH HHS/United States
- U01 MH081902/MH/NIMH NIH HHS/United States
- P50 MH080272/MH/NIMH NIH HHS/United States
- P50 MH066286/MH/NIMH NIH HHS/United States